【Indications】KeBiLi
(Cefradine) Capsules is indicated in the treatment
of the following infections when caused by
susceptible strains of the designated microorganisms:
urinary tract infection; respiratory tract
infection such as bronchitis lobar pneumonia
laryngopharyngitis etc; skin and skin structure
infection; gastrointestinal infection. It
also be used for treatment of tympanitis.
KeBiLi is an oral preparation and is not suitable
for severe infections.
|
|
【Usage &
Dosage】 Oral: 0.25 -0.5 g (1-2capsules)
each time, every 6 hours. Dose may be increased
to 1g (4capsules) each time for severe infections.
The maximum dosage shall not exceed 4 g (16
capsules) per day. For the children, take
6.25-12.5mg/kg according to the weight, every
6 hours. Or follow the instruction of doctors.
|
|
【Contraindications】Cephradine
is contraindicated in patients with known
hypersensitivity to the cephalosporin group
of antibiotics. Administion is forbidden to
penicillin-allegic-shock patient or patient
with immediat reactions to penicillin . |
|
| 【Strength】0.25g |
|
【Packing Specification】10
caps/blister pack/box × 600 boxes/carton;
10 caps/blister pack × 2 blister packs/box
× 600 boxes/carton
|
|
| 【Drug Approval Number】GuoYaoZhunZi
H44021525 |
|
| 【Storage】Keep airtight in
a dry and cool (temperature not above 20℃) place.
Away from light. |
|
| |
|
